Cover of: Therapeutic targets in airway inflammation | Read Online

Therapeutic targets in airway inflammation

  • 85 Want to read
  • ·
  • 51 Currently reading

Published by Marcel Dekker in New York .
Written in English


  • Asthma.,
  • Antiasthmatic agents.,
  • Airway (Medicine) -- Inflammation.,
  • Asthma.,
  • Inflammation.,
  • Respiratory Tract Diseases.,
  • Immunotherapy.,
  • Respiratory System -- physiopathology.,
  • Technology, Pharmaceutical.,
  • Asthma.,
  • Inflammation.

Book details:

Edition Notes

Includes bibliographical references and index.

Statementedited by N. Tony Eissa, David P. Huston.
SeriesLung biology in health and disease ;, v. 177
ContributionsEissa, N. Tony., Huston, David P.
LC ClassificationsRC591 .T48 2003
The Physical Object
Paginationxxxi, 957 p. :
Number of Pages957
ID Numbers
Open LibraryOL3319341M
ISBN 10082470956X
LC Control Number2004270534

Download Therapeutic targets in airway inflammation


COVID Resources. Reliable information about the coronavirus (COVID) is available from the World Health Organization (current situation, international travel).Numerous and frequently-updated resource results are available from this ’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus. TY - BOOK. T1 - Therapeutic targets in airway inflammation. AU - Eissa, N. Tony. AU - Huston, David P. PY - /1/1. Y1 - /1/1. N2 - This reference examines the cellular, molecular, and genetic mechanisms involved in airway inflammation, as well as the pathophysiology, epidemiology, and aetiology of by: 3.   Therapeutic Targets in Airway Inflammation by N. Tony Eissa, , available at Book Depository with free delivery worldwide. Therapeutic Targets in Airway Inflammation (Lung Biology in Health and Disease) 1st Edition by N. Tony Eissa (Editor), David P. Huston (Editor) ISBN ISBN X. Why is ISBN important? ISBN. This bar-code number lets you verify that you're getting exactly the right version or edition of a book. Format: Hardcover.

Get this from a library! Therapeutic targets in airway inflammation. [N Tony Eissa; David P Huston;] -- This reference examines the cellular, molecular, and genetic mechanisms involved in airway inflammation, as well as the pathophysiology, epidemiology, and aetiology of asthma. It . COPD and asthma combined affect at least million people worldwide, making investigation of more therapeutic targets and the development of effective drugs a relevant task in the treatment of these respiratory diseases (Vogelmeier et al., ). COPD and asthma are characterized by airway obstruction, chronic inflammation, and airway by: 8. Abstract: Asthma is a complex disease characterized by variable airflow limitation, hyperresponsiveness, and airways inflammation. Despite valuable therapeutic advances to control asthma symptoms in the last decade, a quantifiable proportion of patients with moderate to severe asthma continue to experience inadequate disease control, highlighting an important unmet need. This present review discusses the role of TIM-containing molecules and their ligands in the lung, as well as their potential as therapeutic targets in airway disease. Keywords: T cell immunoglobulin and mucin-domain, inflammation, galectin-9, airway diseaseCited by: 8.

Title: Adenosine Receptors As Promising Therapeutic Targets for Drug Development in Chronic Airway Inflammation VOLUME: 7 ISSUE: 6 Author(s):Riccardo Polosa and Stephen T. Holgate Affiliation:Dipartimento di MedicinaInterna e Specialistica, Ascoli-Tomaselli Hospitals - University of Catania,Via Passo Gravina , Catania, Italy. The applicability to the human situation and the therapeutic potential of novel findings has also been discussed. The lung contains many subsets of dendritic cells (DCs) that are distributed in various anatomical compartments. Plasmacytoid and myeloid DCs play important roles in establishment of airway inflammation seen in asthma and COPD. MECHANISMS OF AIRWAY SMOOTH MUSCLE CONTRACTILITY AND RELAXATION: POTENTIAL THERAPEUTIC TARGETS. Airway Smooth Muscle-Derived WNT-5A Drives Allergic Airway Inflammation and Remodeling. microRNAp Targets Inositol 1,4,5-Triphosphate-Mediated Signaling Pathways in Asthmatic Airway Smooth Muscle. To explore whether ADAM8 is a therapeutic target for asthma. We reviewed literature on ADAM8's function and expression and activities in lungs of humans and mice with allergic airway inflammation.